The Ophthalmic Drugs Market size is expected to grow at an annual average of 5% during 2021-2027. Ophthalmic drugs are formulations designed to treat eye conditions such as cataracts, glaucoma, color blindness, diabetic macular edema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration (AMD).
(Get 15% Discount on Buying this Report)
A full report of Ophthalmic Drugs Market is available at: https://www.orionmarketreports.com/ophthalmic-drugs-market/27707/
The following segmentation are covered in this report:
By Type
- Prescription Drugs
- Over-the-counter Drugs
By Dosage Form
- Liquid Ophthalmic Drug Forms
- Solid Ophthalmic Drug Forms
- Semisolid Ophthalmic Drug Forms
- Multicompartment Drug Delivery Systems
- Other Ophthalmic Drug Forms
By Distribution Channel
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Others
Company Profile
- AbbVie Inc. (Allergan plc)
- Alcon Inc.
- Bausch & Lomb Incorporated
- Hoffmann-La Roche Ltd (Genentech, Inc.)
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. (Actavis Generics)
The report covers the following objectives:
- Proliferation and maturation of trade in the global Ophthalmic Drugs Market
- The market share of the global Ophthalmic Drugs Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Ophthalmic Drugs Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Ophthalmic Drugs Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
